Funding Round
Neurometrix raises $8M to relaunch Quell wearable pain device with AI personalization
MassDevice4/7/2026·04/07/26🌐 USA
Summary
Woburn-based Neurometrix raised $8M private placement to fund the relaunch of their Quell wearable nerve stimulation device for chronic pain with a new AI personalization layer. Quell 3.0 uses machine learning trained on 200,000 treatment sessions to adapt stimulation protocols to individual pain patterns and response profiles automatically.
Why it matters
Neurometrix's pivot from pure hardware to AI-personalized pain management reflects the broader industry shift toward software-defined therapeutic value. Their 200,000-session dataset is a genuine competitive asset — few consumer neurotech companies have this scale of real-world pain treatment data.
#Neurostimulation#Chronic Pain#Wearables#AI#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in